Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
A straightforward comparison of the Djia and the S&P 500, focusing on diversification, volatility profiles, and historical performance to guide decision making.
22,615 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
The Federal Reserve left rates unchanged and signaled a cautious path ahead, as inflation risks and geopolitical tens...
Disney moved to strengthen its finances ahead of a CEO transition by extending CFO Hugh Johnston's contract, signalin...
Global defense budgets are expanding, driving gains in aerospace and defense equities. The ITA ETF offers access to a...
A new car loan interest deduction could trim tax bills for buyers of eligible U.S.-assembled vehicles. Here’s who qua...
Nvidia delivered a record-breaking quarter, but a steely market mood leaves its stock rangebound. A steward partners ...
Iran tensions and hawkish policy signals are lifting yields, putting mortgage rates breaking higher and spring housin...
Global market shifts in 2026 make international exposure a potential anchor for retirement income and diversification...
The connection between AI investment and inflation could reshape markets. This practical guide translates Powell's re...
Onity Group completes the rebranding of PHH Mortgage to Onity Mortgage, extending the Onity brand across its mortgage...
Two YieldMax income ETFs tied to Berkshire and Microsoft have seen weekly payouts collapse as market volatility dries...
Alibaba is reshaping itself from a pure e-commerce giant into a cloud and AI contender. With profits under pressure a...